Overview

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Ophthalmic Consultants of Long Island
Collaborator:
Ocular Therapeutix, Inc.
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Ketorolac
Ketorolac Tromethamine
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination